Agile Therapeutics, Inc. (NASDAQ:AGRX) Given Average Rating of "Hold" by Analysts
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) has been assigned an average recommendation of “Hold” from the six research firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average 1 year target […]
Agile Therapeutics Inc Goldman Sachs Group Inc Squarepoint Ops Zacks Investment Research Boothbay Fund Management Renaissance Technologies
Source: etfdailynews.com